Oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitors
US11311528B2 · kind B2 · utility
0Cited by
2References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2019 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | Mar 16, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant invention provides compounds of formula I which are STING inhibitors, and as such are useful for the treatment of STING-mediated diseases such as inflammation, asthma, COPD and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.